Zobrazeno 1 - 10
of 272
pro vyhledávání: '"Xiuhua Sun"'
Autor:
Hui Zhou, Jun Zhu, Yu Yang, Wei Yang, Liling Zhang, Lihong Liu, Mingzhi Zhang, Chuan He, Mei Zhang, Sujun Gao, Zhiming Li, Min Zhou, Hongmei Jing, Qingyuan Zhang, Ying Cheng, Yuqin Song, Zhengzi Qian, Xiuhua Sun, Wenyu Li, Haiyan Yang, Feng Yan, Ying Xiang, Bing Xu, Weihua Zhang, Xiaohong Zhang, Jie Jin, Huilan Liu, Weili Zhao, Ru Feng, Wenqi Jiang, Hong Cen, Fangfang Lv, Yunhong Huang, Ding Yu, Qunyi Guo, Lie Lin, Jianzhen Shen, Donghua Zhang, Jishi Wang, Xiongpeng Zhu, Meizuo Zhong, Jingbo Wang, Zhao Wang, Hongguo Zhao
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 10 (2024)
Background In patients with untreated CD20-positive diffuse large B-cell lymphoma (DLBCL), a phase 3 trial was carried out to evaluate the efficacy and safety of zuberitamab plus CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone; Hi-CH
Externí odkaz:
https://doaj.org/article/455cdb1f9ecd4902a56bf02e56ac8ada
Autor:
Ningjing Lin, Xiuhua Sun, Hui Zhou, Liqun Zou, Keshu Zhou, Lihong Liu, Haiyan Yang, Kai Hu, Qingqing Cai, Yao Liu, Jie Jin, Liling Zhang, Wenyu Li, Ye Guo, Wei Yang, Feng Luo, Zhenguang Wang, Rong Zhu, Lei Yang, Dan Song, Yuqin Song, Jun Zhu
Publikováno v:
Haematologica, Vol 999, Iss 1 (2024)
Patients with relapsed or refractory (R/R) diffuse large B-cell lymphoma (DLBCL) have a poor prognosis. Loncastuximab tesirine (Lonca), an antibody conjugate targeting CD19, has demonstrated significant clinical benefit in R/R DLBCL in a global phase
Externí odkaz:
https://doaj.org/article/f8f59c1272c6425db6c5b7bf6bcbf17a
Autor:
Yan Qin, Yongping Song, Dong Wang, Ou Bai, Jifeng Feng, Xiuhua Sun, Lihua Qiu, Jianmin Yang, Yu Yang, Zhao Wang, Jianda Hu, Huaqing Wang, Hang Su, Zhengming Jin, Wenbin Qian, Chuan Jin, Mingzhi Zhang, Ding Yu, Li Liu, Guoan Chen, Yarong Li, Tao Sun, Jie Jin, Huizheng Bao, Xin Du, Hui Zhou, Gan Fu, Yuankai Shi
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract HLX01 (HanliKang®) is a rituximab biosimilar that showed bioequivalence to reference rituximab in untreated CD20-positive diffuse large B-cell lymphoma (DLBCL) in the phase 3 HLX01-NHL03 study. Here, we report the 5-year follow-up results f
Externí odkaz:
https://doaj.org/article/7eecafad55844bb3b801aa99db2e8a55
Autor:
Xiaoxuan Zhao, Mingxi Xu, Xuemeng Hu, Xiaolei Ding, Xian Zhang, Liye Xu, Li Li, Xiuhua Sun, Jincheng Song
Publikováno v:
Stem Cell Research & Therapy, Vol 14, Iss 1, Pp 1-16 (2023)
Abstract Background Exosomes play important roles in intercellular communication by delivering microRNAs (miRNAs) that mediate tumor initiation and development, including those in diffuse large B cell lymphoma (DLBCL). To date, however, limited studi
Externí odkaz:
https://doaj.org/article/338fd085c4254512bb225e75a652b3de
Autor:
Jie Zha, Qinwei Chen, Jingjing Ye, Haifeng Yu, Shuhua Yi, Zhong Zheng, Wei Xu, Zhifeng Li, Lingyan Ping, Xiaohua He, Liling Zhang, Caixia Li, Ying Xie, Feili Chen, Xiuhua Sun, Liping Su, Huilai Zhang, Liyuan Fan, Zhijuan Lin, Haiyan Yang, Weili Zhao, Lugui Qiu, Zhiming Li, Yuqin Song, Bing Xu
Publikováno v:
Biomarker Research, Vol 11, Iss 1, Pp 1-13 (2023)
Abstract Background The difference between clinical characteristics and outcomes between follicular lymphoma grade 1–2 (FL1-2) and FL3a defined pathologically remains unclear, resulting in uncertainty how to treat FL3a. However, it may be crucial f
Externí odkaz:
https://doaj.org/article/06f236a9aacc4665a568296a00e12453
Autor:
Yuchen Zhang, Panpan Liu, Jun Cai, Hongmei Jing, Liqun Zou, Huiqiang Huang, Yuanbin Wu, Wenyu Li, Liye Zhong, Xueli Jin, Xu Ye, Ru Feng, Huilai Zhang, Liling Zhang, Lie Lin, Xiuhua Sun, Yuyang Tian, Zhongjun Xia, Zhiming Li, He Huang, Yi Xia, Qingqing Cai
Publikováno v:
Cancer Medicine, Vol 11, Iss 22, Pp 4134-4145 (2022)
Abstract Background Ibrutinib has revolutionized the treatment of mantle cell lymphoma (MCL). Both ibrutinib monotherapy and ibrutinib‐based combination therapy are important salvage options for patients with relapsed/refractory (R/R) MCL. The real
Externí odkaz:
https://doaj.org/article/436b7378b4a54994a94a31e6fd1a8a22
Autor:
Zhong Zheng, Huilai Zhang, Keshu Zhou, Hui Zhou, LI Zhang, Caixia LI, Min Zhou, Wenbin Qian, Zhiming LI, Qingyuan Zhang, Ying Cheng, Liu Peng, Zhenyu LI, Liping Su, Fei LI, Xiuhua Sun, Jingwen Wang, Yuhuan Gao, Xielan Zhao, Kunyan LI, Kaiyang Ding, Zunmin Zhu, Ying Wang, Hongmei Jing, Xiaohong Xu, Xin Wang, Zimin Sun, Da Gao, Wei-LI Zhao
Publikováno v:
HemaSphere, Vol 7, p e1263860 (2023)
Externí odkaz:
https://doaj.org/article/58a4274135b549a0a6c71633dace5b8d
Autor:
Lihua Qiu, Tingyu Wang, Xiuhua Sun, Hang Su, Junning Cao, Zhi-Ming LI, Yuqin Song, LI Zhang, Dengju LI, Huijing Wu, Wei Zhang, Junmin LI, Keshu Zhou, Hui Zhou, Yu Yang, Zhifeng LI, Hong Cen, Zhen Cai, Zhihui Zhang, Weijun Fu, Jie Jin, Fei LI, Weixin Wu, Xuekui Gu, Weiliang Zhu, Lihong Liu, Zengjun LI, Shuhua Yi, Lugui Qiu
Publikováno v:
HemaSphere, Vol 7, p e37624bc (2023)
Externí odkaz:
https://doaj.org/article/00ba39c9e3dd4c03ada9c800daf17187
Autor:
Xiuhua Sun, Tingyu Wang, Lihua Qiu, Hang Su, Junning Cao, Zhi-Ming LI, Yuqin Song, LI Zhang, Dengju LI, Huijing Wu, Wei Zhang, Junmin LI, Keshu Zhou, Hui Zhou, Yu Yang, Zhifeng LI, Hong Cen, Zhen Cai, Zhihui Zhang, Weijun Fu, Jie Jin, Fei LI, Weixin Wu, Xuekui Gu, Weiliang Zhu, Lihong Liu, Zengjun LI, Shuhua Yi, Lugui Qiu
Publikováno v:
HemaSphere, Vol 7, p e46591f9 (2023)
Externí odkaz:
https://doaj.org/article/15381915b0f04f48bee2299143d8860b
Publikováno v:
Clinical Case Reports, Vol 10, Iss 11, Pp n/a-n/a (2022)
Abstract Hemophagocytic lymphohistiocytosis (HLH) is a severe syndrome of pathological immune activation caused by activated macrophages and cytotoxic T cells. We report a 65‐year‐old male Chinese patient with typical HLH features caused by perip
Externí odkaz:
https://doaj.org/article/3ca45e77e3b64c80aadad6d1651de601